News A re-brand for US generics and biosimilars sector Body will campaign to "Keep Medicines in Reach"
News NICE rejects second Alexion ultra-rare disease drug NHS will not fund Kanuma for rare disease LAL-D.
News Norgine rejoins ABPI after eight year absence ABPI says Norgine's support will be important during Brexit.
News Acacia ready to file its anti-vomiting treatment Potential launch in 2018 if FDA approves Baremsis.
News Biotech leaders unite against Trump travel ban Spokesman also causes confusion over pricing policy.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
